BARISON, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.311
EU - Europa 2.669
AS - Asia 654
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 8
Totale 6.669
Nazione #
US - Stati Uniti d'America 3.173
IT - Italia 771
GB - Regno Unito 670
DE - Germania 407
SG - Singapore 336
UA - Ucraina 261
RU - Federazione Russa 139
CA - Canada 135
VN - Vietnam 130
CN - Cina 122
DK - Danimarca 117
SE - Svezia 97
FR - Francia 69
FI - Finlandia 43
IE - Irlanda 40
HK - Hong Kong 34
PL - Polonia 15
EU - Europa 11
NL - Olanda 9
BR - Brasile 8
IN - India 8
LT - Lituania 5
AR - Argentina 4
BD - Bangladesh 4
BE - Belgio 4
CH - Svizzera 4
IR - Iran 4
PK - Pakistan 4
HR - Croazia 3
MA - Marocco 3
SM - San Marino 3
TH - Thailandia 3
CO - Colombia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JP - Giappone 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 6.669
Città #
Southend 444
Chandler 314
Houston 290
Singapore 271
Fairfield 252
Ann Arbor 241
Woodbridge 224
San Mateo 200
Wilmington 137
Seattle 135
Cambridge 129
Falls Church 129
Dearborn 108
Jacksonville 107
Ashburn 103
Ottawa 100
Boardman 92
Stevenage 79
Portsmouth 78
Dong Ket 68
Pisa 66
Beijing 63
Lawrence 57
Rome 41
Dublin 38
San Diego 34
Santa Clara 33
Milan 31
Florence 23
Brooklyn 22
Central District 21
London 21
Montréal 21
Redwood City 21
Los Angeles 16
Dallas 15
Helsinki 14
Palermo 14
Warsaw 13
Bari 12
Munich 12
Norwalk 11
Napoli 10
Old Bridge 10
Salerno 10
Fremont 9
Padova 9
Bologna 8
Hong Kong 8
Redmond 8
Toronto 8
Frankfurt am Main 7
Naples 7
Assago 6
Cascina 6
Dongguan 6
Grammichele 6
Lappeenranta 6
Shanghai 6
Turin 6
Veglie 6
Pavia 5
Perugia 5
Reggio Calabria 5
Wandsworth 5
Acton 4
Augusta 4
Brussels 4
Chiswick 4
Genoa 4
Guangzhou 4
Livorno 4
Lyon 4
Tehran 4
Agordo 3
Barletta 3
Chicago 3
Fabriano 3
Ferrara 3
Honolulu 3
Hounslow 3
Lucca 3
Mountain View 3
Oristano 3
Paris 3
Serra 3
Venice 3
Washington 3
Zagreb 3
Amsterdam 2
Basel 2
Berlin 2
Bratislava 2
Bucharest 2
Cagliari 2
Como 2
Cosenza 2
Debrecen 2
Faenza 2
Federal 2
Totale 4.365
Nome #
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 577
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 220
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 183
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 180
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 176
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 175
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 171
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 162
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 161
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 158
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 155
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 153
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 152
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 151
Update sui biomarcatori nello scompenso cardiaco. 151
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 151
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 149
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 148
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 147
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 135
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 130
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 129
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 128
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 117
Sex-related differences in chronic heart failure 114
A simple echocardiographic score to rule out cardiac amyloidosis 112
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 97
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 94
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 83
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 79
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 77
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 77
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 76
Troponin in non-ischaemic dilated cardiomyopathy 75
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 72
Treatment of cardiac transthyretin amyloidosis: an update 61
Molecular autopsy of sudden cardiac death in the genomics era 58
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 57
Role of Imaging in Cardiomyopathies 56
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 56
Cardiovascular disease and COVID-19: les liaisons dangereuses 56
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 55
A simple echocardiographic score to rule out cardiac amyloidosis 54
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 54
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 53
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 53
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 52
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 51
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 50
Colchicine for the treatment of coronary artery disease 46
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 46
Cardiac magnetic resonance in patients with muscular dystrophies 45
The Barthel Index in elderly acute heart failure patients. Frailty matters 45
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 43
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 42
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 42
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 40
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 40
The unbearable underreporting of comorbidities in heart failure clinical trials 36
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 33
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 33
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 31
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 30
Valvular heart disease in patients with cardiac amyloidosis 29
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 26
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 26
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 26
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 25
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 24
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 21
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 21
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 20
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 18
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 18
Partial Lipodystrophy and LMNA p.R545H Variant 17
Perspectives in noninvasive imaging for chronic coronary syndromes 17
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 16
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 15
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 11
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 10
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 9
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 8
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 6
Totale 6.796
Categoria #
all - tutte 48.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020399 0 0 0 0 0 102 98 21 61 21 23 73
2020/20211.519 110 120 54 114 96 179 136 74 160 112 171 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/2025743 45 54 208 67 166 203 0 0 0 0 0 0
Totale 6.796